Live at the HIMSS 2017 Conference in Orlando FL, an interesting interview with Ken Perez, Vice President of Healthcare Policy at Omnicell, Inc.
Industry experts are predicting that a slow repeal of the ACA will have very little, if any, negative impact on healthcare technology. Healthcare technology grew at an unprecedented pace under the ACA, in part because the ACA contains provisions which provide healthcare technology with incentives to develop and implement new systems aimed at increasing efficiency.
Despite the significant amount of uncertainty with a slow repeal of the ACA for many players in the healthcare industry, healthcare technology appears to be poised for continued growth through value-based care, telemedicine, and the increased need for interoperability.
About Ken Perez:
Ken Perez, in this hybrid role combining thought leadership, marketing, and business development, serve as the company’s subject matter expert on health reform, accountable care organizations (ACOs) and population health management, analytics, patient safety, and medication adherence.
Ken lead multiple multi-functional team initiatives, including the Industry Intelligence Delta Team, Medication Management Council, and Pharmacy Forums. Engage directly with integrated delivery network clients. Drive scenario planning, strategy, and M&A activities for analytics, patient safety and medication adherence, working closely with the product marketing and marketing communications teams.
• Architected a medication adherence solution suite framework and identified acquisition targets to supplement the company’s existing offerings.
• Conceptualized, researched and provided the content as well as design direction for the company’s Medication Adherence Resource Center, an online educational service that is an industry first.
• Chosen to speak on health reform, ACOs, analytics, and big data at healthcare industry events.
Omnicell (NASDAQ: OMCL), a healthcare IT firm with approximately $700 million in annual revenue and a market capitalization of roughly $1.3 billion, provides comprehensive automation and business analytics software for patient-centric medication and supply management across the entire healthcare continuum–from hospitals to the home.